Evidence map›Paper›PMID 40657404›Full record

Article3 Biotech2025

Nephroprotective and therapeutic potential of

Suray Pehlivanoglu, Cigdem Aydin Acar, Sebnem Pehlivanoglu, Sukriye Yesilot, Hatice Ceylan

Abstract read
In one paragraph

Article in 3 Biotech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suray PehlivanogluDepartment of Molecular Biology and Genetics, Faculty of Science, Necmettin Erbakan University, Konya, Turkey.ORCID 0000-0001-7422-2974
Cigdem Aydin AcarDepartment of Health and Biomedical Sciences, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.ORCID 0000-0002-1311-2314
Sebnem PehlivanogluDepartment of Medical Biology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.ORCID 0000-0003-0817-0891
Sukriye YesilotDepartment of Health and Biomedical Sciences, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.ORCID 0000-0003-3354-8489
Hatice CeylanDepartment of Nursing, Bucak School of Health, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.ORCID 0000-0001-6423-6010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a severe form of kidney disease that is characterized by dysfunction. Excessive production of reactive oxygen species (ROS) is a major contributing factor in AKI pathogenesis. This study aims to investigate the cytoprotective effects of

Indexed as

Antioxidant and antiapoptotic effectsHelichrysum orientale (L.) Gaertn.Kidney injury

Identifiers

PMID40657404
PMCPMC12254448

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.